Life360, Inc. (LIF) Peer Comparison

$42.68

$1.12 (2.69%)

As on 11-Sep-2026 16:00EDT

Market cap

$3,478 Mln

Revenue (TTM)

$573 Mln

P/E Ratio

24.1

P/B Ratio

5.5

Div. Yield

0 %

Edit

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Market cap ($ Mln)	3,478	4,500	10	2
Revenue ($ Mln)	573	1,206	6	2
Net Profit ($ Mln)	147.29	134.79	0.07	-18.75
Net Margin (%)	25.72	11.18	1.20	-1,003.19
RoE (%)	25.36	3.43	--	-130.74
Price to Earnings	24.11	33.06	--	--
Price-To-Book	5.52	1.11	1,802.81	0.46

Income Statement ($ Mln)

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Operating Revenue	572.56	1,205.74	2.05	1.87
Cost of Revenue	128.30	372.49	1.39	0.65
Gross Profit	380.84	751.12	0.66	0.03
Operating Expenses	437.75	557.49	0.93	15.71
Operating Profit (EBIT)	6.51	275.76	-0.27	-16.52
Other Income	0.00	0.00	--	0.00
Profit before Tax	14.06	195.08	-0.28	-17.84
Provision for Tax	-133.23	60.29	--	0.00
Profit after Tax (Net Income)	147.29	134.79	-0.28	-18.75
Minority Interest	0.00	0.00	--	0.00
Consolidated Profit	0.00	0.00	--	0.00

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Shareholder's Funds	613.43	3,986.24	-0.17	11.89
Minority Interest	0.00	0.00	--	0.00
Non-Current Liabilities	331.45	1,644.80	0.37	17.54
Current Liabilities	107.04	237.72	0.51	3.05
Total Liabilities	959.69	5,785.10	0.71	31.61

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Non-Current Assets	452.42	5,429.79	0.26	29.09
Current Assets	599.50	438.97	0.45	3.38
Total Assets	959.69	5,785.10	0.71	31.61
Total Debt*	311.48	1,481.72	0.35	17.41
Net Current Assets	492.46	201.25	-0.14	0.34

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Cash From Operating Activities	88.63	309.67	-0.21	-7.00
Cash Flow from Investing Activities	-35.33	-680.90	--	-0.71
Cash from Financing Activities	282.07	243.45	0.16	18.35
Net Cash Inflow / Outflow	--	--	--	--

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
ROCE (%)	24.76	2.31	-2,636.14	-68.86
ROE (%)	25.36	3.43	170.10	-130.74
ROA (%)	14.84	2.46	-39.73	-91.80
EBIT Margin (%)	2.46	22.87	--	-745.03
Net Margin (%)	25.72	11.18	-13.81	-1,003.19
Cash Profit Margin (%)	0.00	0.00	--	0.00

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Revenue Growth (%)	33.96	19.23	0.00	--
EBIT Growth (%)	-29.77	31.10	--	--
Net Profit Growth (%)	434.21	56.83	0.00	-56.99
EPS Growth (%)	421.74	47.40	--	-2.94
Book Value Growth (%)	65.12	17.28	--	-7.97

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Price / Earnings	36.22	57.66	--	-0.04
Price / Book Value	5.52	1.11	--	0.46
Dividend Yield (%)	0.00	0.00	--	0.00
EV/EBITDA	100.49	13.66	--	0.26
Market Cap ($ Cr)	--	--	--	--

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Debt to Equity	0.51	0.36	-2.13	0.62
Short term debt to equity ratio	0.00	0.00	-0.75	0.04
Current Ratio	5.60	1.85	0.88	1.11
Quick Ratio	5.46	1.84	--	0.86
Interest Coverage	--	3.42	-31.30	-11.95

	Life360, Inc. (LIF)	Waystar Holding Corp. (WAY)	Morningstar US Mid Cap PR USD (MMCP)	Valion Bio Inc (VBIO)
Debtors to sales (%)	17.21	15.42	--	76.95
Asset Turnover	0.58	0.22	2.88	0.09
Receivable days	53.89	55.08	--	33.47
Inventory Days	30.13	--	--	332.90
Payable days	23.32	51.57	80.44	202.97
Cash Conversion Cycle	60.70	--	--	163.39

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.